Keywords: Organ donation; Biomarker; Clinical trial; Transplantation; Risk prediction; Brain death; IL-6; interleukin-6; SLPI; secretory leukocyte protease inhibitor; IDI; integrated discrimination improvement; DND; donation after neurologic death; MOnIToR; Monitor
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Anticoagulants; Cytokine; Luminex; Validation; Serum; Plasma; IL; interleukin; CC; CC-chemokine (beta chemokine); CXC; CXC-chemokine (alpha chemokine); XC; C-chemokine (gamma chemokine); TNF; tumor necrosis factor; IFN; interferon; LIGHT; homologous to ly
Keywords: SLPI; secretory leukocyte protease inhibitor; CF; cystic fibrosis; Smartphone; mHealth; Point-of-care; Electrochemical biosensor; Audio jack; Power rectification;
Keywords: Nasal mucus; proteome; proteomics; allergic rhinitis; mass spectrometry; A2M; α2-Macroglobulin; APOA1; Apolipoprotein A-1; APOA2; Apolipoprotein A-2; APOA4; Apolipoprotein A-4; APOB; Apolipoprotein B-100; BPIFA1; BPI fold-containing family A member 1;
miRNA-expression in tonsillar squamous cell carcinomas in relation to HPV infection and expression of the antileukoproteinase SLPI
Keywords: SLPI; HNSCC; Tonsils; Survival; HPV, miRNA;
Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort
Keywords: SLPI, secretory leukocyte protease inhibitor; HPV, human papillomavirus; HNC, head and neck cancer; HNSCC, head and neck squamous cell carcinomaSecretory leukocyte protease inhibitor; SLPI; Innate immunity; Head and neck cancer; Oral disease; Mouthwash
Human uterus myoma and gene expression profiling: A novel in vitro model for studying secretory leukocyte protease inhibitor-mediated tumor invasion
Keywords: Myoma; Gene expression profiling; Tumor invasion; SLPI; Matrix metalloproteinase
Predictive biomarkers of preterm delivery in women with ongoing IVF pregnancies
Keywords: IVF; in vitro fertilization; PTD; preterm delivery; HE4; human epididymal protein 4; SLPI; secretory leukocyte protease inhibitor; IGF-I; insulin-like growth factor; IGF-II; insulin growth factor II; IGFBP-1; insulin growth factor binding protein-1; IVF-E
Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway
Keywords: SLPI; pIgR; Epithelial cells; NF-κB;
The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma
Keywords: SLPI; Annexin A2; HNSCC; HPV;
Targeting Nrf2-Keap1 signaling for chemoprevention of skin carcinogenesis with bioactive phytochemicals
Keywords: 4-HNE; 4-hydroxynonenal; 8OH-dG; 8-hydroxy-2â²deoxyguanosine; AMPK; cyclic-AMP-activated protein kinase; ARE; antioxidant response element; ATF; activating transcription factor; B[a]P; Benzo[a]pyrene; Bach1; broad-complex, tramtrack and bric a brac; CBP;
Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligand
Keywords: Chronic obstructive pulmonary disease; dendritic cells; regulatory T cells; IL-27; IL-10; inducible costimulator ligand; AHR; Aryl hydrocarbon receptor; APC; Antigen-presenting cell; BAL; Bronchoalveolar lavage; CD1c+DCCOPD; CD1c+ DCs from lung samples ob
Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: A therapeutic alternative?
Keywords: Candida albicans; SLPI; Virulence factors; Protease inhibitor;
Quantification of secretory leukocyte protease inhibitor (SLPI) in oral gargle specimens collected using mouthwash
Keywords: SLPI; secretory leukocyte protease inhibitor; HPV; human papillomavirus; HNC; head and neck cancer; OD; optical density; CV; coefficients of variation.; Secretory leukocyte protease inhibitor; SLPI; Innate immunity; Immune system protein; Oral disease; Or
NMR and molecular modelling studies on elastase inhibitor-peptides for wound management
Keywords: MMPs; matrix metalloproteinases; PPE; porcine pancreatic elastase; SLPI; secretory leukocyte protease inhibitor; Pep4; KRCCPDTCGIKCL; Pep4(P); Pep4 phosphorylated; Pep4M; KRMMPDTMGIKML; Pep4M(P); Pep4M phosphorylated; PepBBI (Bowman-Birk inhibitor); WCTAS
Sulforaphane induces SLPI secretion in the nasal mucosa
Keywords: SLPI; Sulforaphane; Nasal mucosa
Inflammatory mediators in exhaled breath condensate of healthy donors and exacerbated COPD patients
Keywords: SLPI; COPD; Exhaled breath condensate; MPO; IFNγ
Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation
Keywords: Nrf2; NF-E2-related factor 2; BM; bone marrow; BMT; bone marrow transplantation; LDL; low density lipoprotein; CM; chylomicron; HDL; high-density lipoprotein; TG; triglyceride; CHO; cholesterol; VCAM-1; vascular cell adhesion molecule 1; ICAM-1; intercell
Endocrine control of mucosal immunity in the female reproductive tract: Impact of environmental disruptors
Keywords: FRT; female reproductive tract; GM-CSF; granulocyte macrophage colony stimulating factor; SLPI; secretory leukocyte protease inhibitor; HBD2; human β defensin 2; MIP; macrophage inflammatory protein; MCP-1; Monocyte chemotactic protein-1; IL; interleukin
Role of the endogenous elastase inhibitor, elafin, in cardiovascular injury: From epithelium to endothelium
Keywords: HNE, human neutrophil elastase; PAR, protease activated receptor; MMP, matrix metalloproteinase; TIMP, tissue inhibitors of metalloproteases; PAI-1, plasminogen activator inhibitor type-1; TFPI, tissue factor pathway inhibitor; α1-PI, α1-antitrypsin; SLPI
Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells
Keywords: Ovarian cancer; SLPI; MMP-9; Metalloproteinase
Lung protease/anti-protease network and modulation of mucus production and surfactant activity
Keywords: Neutrophil elastase; Elafin; SLPI; Surfactant proteins; Mucus; AE; alveolar epithelial cells type I (I) or type (II); AM; alveolar macrophage; AR; amphiregulin; BALF; bronchoalveolar lavage fluid; CF; cystic fibrosis; COPD; chronic obstructive pulmonary d
Expression and characterization of recombinant human secretory leukocyte protease inhibitor (SLPI) protein from Pichia pastoris
Keywords: Human secretory leukocyte protease inhibitor; SLPI; Pichia pastoris; Recombinant protein; HIV
Histochemical localization of neutral proteases released during development of rat periradicular lesion
Keywords: Neutrophil elastase; Cathepsin G; Collagenase 2; Gelatinase B; SLPI; Periradicular lesion
Gene expression profiling during Forskolin induced differentiation of BeWo cells by differential display RT-PCR
Keywords: BeWo cells; DD-RT-PCR; Cell differentiation; SLPI
Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family
Keywords: Serine protease; Protease inhibitors; Inflammation; SLPI; Elafin; Trappin-2α1-PI, alpha1-proteinase inhibitor; ECM, extracellular matrix proteins; LPS, lipopolysaccharide; SNP, single nucleotide polymorphism
A Pilot Study of Fecal Serine-Protease Activity: A Pathophysiologic Factor in Diarrhea-Predominant Irritable Bowel Syndrome
Keywords: IBS; irritable bowel syndrome; IBS-A; irritable bowel syndrome with alternating habits; IBS-C; constipation-predominant irritable bowel syndrome; IBS-D; diarrhea-predominant irritable bowel syndrome; PAR; proteinase-activated receptor; SLPI; secretory leu
Innate Immune Defences in the Human Uterus during Pregnancy
Keywords: Pregnancy; Placenta; Fetal membranes; Innate immunity; Defensins; SLPI; Elafin
Protease inhibitors and their peptidomimetic derivatives as potential drugs
Keywords: α1-PI; alpha1-protease inhibitor; 3D-QSAR; three-dimensional quantitative structure-activity relationship; ACE; angiotensin-converting enzyme; AIDS; acquired immune deficiency syndrome; BBI; Bowman-Birk inhibitor; BBIC; Bowman-Birk inhibitor concentrat
Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women
Keywords: SLPI; Menopausal women; Uterine cervix
Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis
Keywords: CA125; Ovarian tumor; SLPI;
Selective suppression of Toll-like receptor 4 activation by chemokine receptor 4
Keywords: TLR; Toll-like receptor; CXCR4; chemokine receptor 4; LPS; lipopolysaccharide; SDF-1; stromal-cell derived factor-1; NFκB; nuclear factor kappa B; SLPI; secretory leucoprotease inhibitor; HSP; heat shock protein; Lipopolysaccharide; Toll-like receptor 4;
5-Azacytidine suppresses RNA polymerase II recruitment to the SLPI gene
Keywords: Histone methylation; Inflammation; Methylase inhibitor; RNA polymerase II; IL-1β; SLPI;
Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function
Keywords: IkB; inhibitor for NF-κB; IKK; IkB kinase; IRAK; IL-1 receptor associated kinase; MyD88; myeloid differentiation antigen 88; SLPI; secretory leukocyte protease inhibitor; TIR; toll IL-1 receptor; TIRAP; TIR domain-containing adapter protein; TRAF; TNF re